Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP in Pharmacy - Pilot study
PACTR202009710020465Not yet recruiting
- Sponsor
- University of Washington
- Start
- Aug 2020
- Countries
- 1
01
Overview
Open-label trial in human immunodeficiency virus infection (HIV) (2 cohorts), sponsored by University of Washington. Primary endpoints: PrEP initiation, PrEP retention and 1 more. Planned start Aug 2020; status: not yet recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202009710020465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009710020465.